Clinical Trial Update: The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated

View source ↗

Summary

This clinical trial update discusses investigating empagliflozin's effects on glucose metabolism, weight, blood pressure, and NT-proBNP-related cardiac function…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: RWTH Aachen University | Conditions: Diabetes Mellitus, Type 2 | Status: UNKNOWN